Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
Clinical trial NCT03978624 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03978624
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2024-03-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.